grammed", cell death, little is known about the molecular events that mediate this process. That a conserved biochemical pathway exists is suggested by the observation that programmed cell death is almost always accompanied by a consistent set of morphologic changes, an appearance known as apoptosis (2) .
The identification of the genes that control programmed cell death in higher eukaryotes has been hampered by several inherent difficulties. First, the genetic tools so useful in dissecting cell death pathways in Caenorhabditis elegans (3) and Drosophila (4) have not been available in higher eukaryotes. Second, the death-inducing properties of such genes makes genetic selection an impractical means of identification. Third, it appears that many cell death genes are constitutively expressed and present in an inactive formn (5) , making it unlikely that they could be discovered by techniques relying upon differential gene expression. Finally, genes identified by virtue of an ability to induce death when overexpressed must be subjected to rigorous criteria to determine whether the cell death is of physiologic importance, since it is likely that overexpression of certain proteins may lead to toxic effects that are distinct from the in vivo roles of those proteins.
Two approaches to date have yielded the most information about cell death processes: (i) identification of cell death genes by classical genetic means coupled with characterization of their mammalian homologs and (ii) screening for proteins capable of inducing cell death directly in mammalian cells. The Fas antigen/APO-1 is an example of a protein discovered using the latter approach, as it was first discovered as an inducer of cell death and later shown to be necessary and sufficient for certain programmed deaths in vivo. More recent studies have connected Fas to elements of cell death pathways in other species. It has been proposed that Fas is related to the Drosophila cell death protein Reaper, and that in signaling cell death Fas relies upon a relative of the C. elegans cell death protein CED-3. Fas may therefore represent an evolutionarily conserved component of a universal cell death pathway.
IN VIVO FUNCTIONS OF FAS AND ITS ROLE IN HUMAN DISEASE
Fas/APO-1 was identified independently by two groups performing monoclonal antibody screening. The antibodies were chosen for analysis sues such as thymus, lung, heart, and liver) and bears a strong similarity in its extracellular domain to members of the tumor necrosis factor family of receptors (TNF-Rs). This family includes the p75 nerve growth factor receptor, CD40, CD30, CD27, 4-1BB, and OX40 (among others) and is characterized by a cysteine-rich extracellular repeat motif; not surprisingly, the ligands for these receptors are also remarkably well conserved (reviewed in Ref. 10) . At first glance, the cytoplasmic domain of Fas/APO-1 had no observed similarity to proteins outside of this family, although a relationship to several other proteins has now been appreciated (described below). Among members of the family, Fas/APO-1 bears the greatest resemblance (51% similarity) to the TNF-R type 1 (TNF-R1; p55 TNF-R) over a 45-amino acid stretch (8) . Many of the models of Fas/APO-1 signaling have therefore been based on known components of the TNF-R1 pathway.
Mutations in the fas gene are responsible for the recessive lymphoproliferation (lpr) phenotype in mice (1 1). lpr mice develop a progressive lymphadenopathy and immune complex syndrome that resembles the human autoimmune disease systemic lupus erythematosus. Two mutations can lead to the phenotype: an insertion, which prevents normal processing of precursor RNA, and a point mutation in the cytoplasmic domain that renders Fas/APO-1 incapable of transmitting the death signal. When the ligand for Fas/APO-1 was cloned (FasL [12] ), a mutation in this gene was found to cause the phenotype seen in the mouse mutant gld, a non-allelic phenocopy of lpr (13, 14) . These studies demonstrated that both the receptor and its ligand are needed for the elimination of immune cells capable of recognizing self-antigen-a process known as "tolerance" to self-antigen.
How do mutations in these cell death genes lead to autoimmune disease? The answer to this question may rest with alterations in the process of activation-induced cell death (AICD), which occurs when certain T cells are triggered through the T-cell receptor (15 (33) , and that the HIV proteins Tat and gp 120 can directly sensitize cells to the effects of Fas/APO-1 (34) . A cell death pathway involving Fas/APO-1 may therefore underlie the T-cell depletion seen in AIDS, making the elucidation of this pathway all the more important.
EVIDENCE THAT FAS/APO-1 SELF-ASSOCIATES
The sequence of the Fas/APO-1 cytoplasmic domain contains no obvious clues about the mechanism of cell killing; in particular, the intracellular portion of Fas/APO-1 has no recognizable kinase or phosphatase domains, no SH2 or SH3 docking motifs, nor homology to other membrane proteins involved in regulating cell death (e.g., bcl-2). However, as mentioned above, the Fas/APO-1 cytoplasmic domain does have a region with significant similarity to the TNF-R1 cytoplasmic domain. On the basis of this homology, deletion and mutation analyses were performed which showed that this homology region is important for the ability of both molecules to induce cell death (35) , and gave rise to the name "death domain" to refer to this conserved region (36) . It was hypothesized that the death domain may serve as a protein-protein interaction motif, with the attractive possibility that both Fas/APO-1 and TNF-R1 may signal cell death through their interaction with a common intracellular ligand.
A model soon developed that held Fas/ APO-1 aggregation as the principle means of receptor activation (Fig. IA) . Studies of receptor tyrosine kinases had already given precedent to the notion that receptor signaling may occur through aggregation and subsequent association with cytoplasmic proteins through interaction domains (reviewed in Ref. 37 ). Several observations suggested that aggregation is likewise important in Fas/APO-1 signaling. Dhein et al. (38) demonstrated that crosslinking is required for transmission of the Fas/APO-1 death signal, such that F(ab')2 preparations of anti-Fas/APO-1 antibodies are unable to induce apoptosis unless an anti-Ig F(ab')2 crosslinking antibody is also present. The crystal structure of ligand-bound TNF-R1 extracellular domain showed that this complex exists as a trimer (39 Attempts to document Fas/APO-1 self-association by co-immunoprecipitation from cells have been disappointing. The best evidence to date for an interaction comes from the yeast two hybrid method (42) . Experiments utilizing this system have shown a capacity for self-association of the cytoplasmic domains of both Fas/APO-1 (43, 44) and TNF-R1 (43, 45) , as well as a weak association between the cytoplasmic domains of the two receptors (43) . The ability of a death domain to self-associate has also been demonstrated in vitro, as fusion proteins consisting of the cyto- plasmic domain of TNF-R1 fused to the E. coli maltose binding protein or glutathione-S-transferase are capable of binding to each other (43) .
Additional support for the notion that death domains can mediate protein oligomerization comes from the finding that two proteins capable of interacting with the Fas/APO-1 cytoplasmic domain (MORT1/FADD and RIP) and one capable of interacting with the TNF-R1 cytoplasmic domain (TRADD) all contain death domains (44, (46) (47) (48) . Although extensive pairwise testsof-association have not been performed with death domain-containing proteins, there is some specificity to their binding: the death domaincontaining proteins identified so far are capable of interacting with some but not all other members of the family (Fig. 1B) .
Both MORT1/FADD and RIP are incapable of binding a mutant Fas/APO-1 bearing a mutation analogous to the inactivating point mutation in the lpr death domain. Moreover, MORT1 /FADD and RIP can bind to a mutant Fas/APO-1 missing the 15 C-terminal amino acids, which are not required for Fas/APO-1 to induce cell death (35 (58, 59) . Although the participation of these protein kinases in TNF-R signaling is well established, it is unclear whether they are relevant to Fas signaling. In addition, the death domain of TNF-R1 itself has been shown to interact with a Ser/Thr protein kinase (60, 61 (69) .
Other membrane-proximal pathways may be used to transduce the Fas/APO-1 death signal. Fas/APO-1 ligation causes the rapid activation of sphingomyelinase, which makes ceramide by cleaving the phosphocholine-linked sphingoid fatty acid sphingomyelin (70, 71) . Sphingomyelinase and ceramide are themselves pro-apoptotic, leading to cell death and DNA fragmentation within 3 to 6 hr (72, 73) . However, the role of this fatty acid intermediate in Fas/APO-1 signal transduction is still undetermined, and at least one study failed to find ceramide release during Fas-or TNF-induced killing of the breast carcinoma line MCF7 (74) . In addition, overexpression of a ras dominant negative mutant or microinjection of anti-Ras antibodies was able to partially block cell death, suggesting that part of the Fas/APO-1 pathway utilizes Ras (75) . Most Tyr phosphorylation events following Fas ligation on Jurkat cells are not altered by blocking Ras, although overexpression of the dominant negative Ras did inhibit the tyrosine phosphorylation of one -97-kD protein; notably, this protein has the same molecular weight as ceramideactivated protein kinase (76) .
Thus, many possibilities still exist for the initial steps in Fas/APO-1 signaling, including death-inducing proteins capable of interacting directly with Fas, and complex interactions among kinases, phosphatases, fatty acids, and possibly Ras. Furthermore, the observation that under certain circumstances Fas can transmit activation as well as death signals (77-80) highlights the regulatory complexity that is likely to underly Fas/APO-1 signaling.
CYSTEINE PROTEASES
One guiding hypothesis in cell death research has been the prospect (and hope) that an evolutionarily conserved final common pathway may serve as the convergence point for multiple cell death stimuli (81, 82) . Two genes identified through mutant analysis and known to be required for most programmed cell deaths in C. elegans, ced-3 and ced-4 (3), have been obvious candidates for such a process. The ced-3 gene has been cloned (83) and encodes a protein which resembles the mammalian interleukin lf-converting enzyme (ICE) (84), a cysteine protease that cleaves after Asp residues. ICE belongs to a family of cysteine proteases that includes Nedd2/ ICH-1, CPP32, and ICH-2 (reviewed recently in Ref. 85) . Transient overexpression of most members of the family induces cell death (Ref. 86 and those above). Of note, the cytotoxic granule protein Fragmentin 2/granzyme B is also a protease with Asp specificity (87) . Fragmentin 2 is capable of inducing cell death (88) , and appears to do so by cleaving CPP32 (89) .
Strong support for the notion that a cysteine protease is required for Fas/APO-1 killing came from the finding that both the cowpox-encoded ICE-inhibitor CrmA and/or a noncleavable IL-1,3 transition state analogue (Ac-Tyr-Val-Ala-Aspaldehyde) could prevent Fas-induced apoptosis (90) (91) (92) . Several approaches have been taken to determine which protease(s) are responsible, including an in vitro system in which many of the morphologic and biochemical hallmarks of apoptosis are preserved (93) . One such hallmark is the cleavage by an Asp-specific protease of poly-(ADP-ribose) polymerase (PARP) to an 85-kD fragment both in vivo and in vitro. The enzyme which carries out this cleavage can be blocked by tetrapeptide inhibitors of ICE and is thus presumed to be a cysteine protease. This protease is distinct from ICE (since purified ICE could not cleave PARP) and was called prICE, for protease resembling ICE (93) .
Recent studies have suggested that prICE is identical to the CED-3 relative CPP32 (also called Yama or apopain), and that CPP32 is the key protease required for Fas/APO-1-mediated killing. Tewari et al. (94) showed that PARP is cleaved following Fas crosslinking and that purified, activated CPP32 can cleave PARP in a CrmA-inhibitable manner. More direct evidence that prICE is CPP32 came from the biochemical purification of prICE using peptide binding and PARP cleavage as assays (95) . CPP32 is produced as a 32 kD proenzyme that is cleaved at two Asp residues to yield the active p 17 and p1 2 subunits.
Among known cysteine proteases, CPP32 and the C. elegans CED-3 protein are most closely related, as might be expected for the mammalian homolog of the nematode cell death protease.
Mice bearing a targeted mutation in the ICE gene have a relative resistance to anti-Fas induced killing, suggesting that ICE itself plays some role in the Fas/APO-1 pathway (96), although several forms of thymocyte death appear to be normally intact in ICE-"knock-out" mice (97 bcl-2 bcl-XL ICE tive form (94) , and thus it may activate CPP32 in vivo. However, osteosarcoma cells containing high levels of active CPP32 have no detectable ICE (95) , suggesting that other enzymes are capable of catalyzing cleavage of the CPP32 proenzyme.
OTHER MODULATORS OF FAS/APO-1 SIGNALING
Another evolutionarily conserved component of cell death regulation involves the Bcl-2 family of membrane proteins, which are capable of forming homo-and hetero-dimers that serve as a "rheostat" to positively or negatively influence cell death decisions (reviewed in Ref. 98) . Bcl-2 is homologous to the protein encoded by the ced-9 gene of C. elegans (81) , which acts as a negative regulator of ced-3-induced cell death (99) . Since Fas killing requires a ced-3-like cysteine protease, it has been postulated that Bcl-2 family members also regulate death signals from Fas.
Bcl-2 can partially protect cells from Fas/ APO-1-mediated apoptosis (100), and coexpression of the Bcl-2 binding protein BAG-1 fully protects cells (101) . The Bcl-2 relative BCl-XL is also capable of inhibiting Fas-mediated cell death (74, 102 sive for induction of apoptosis through Fas/ APO-1. However, there are clearly other means of achieving Fas-resistance, since variability in Fas-responsiveness has been seen despite a uniform absence of Bcl-2 expression in a number of non-hematopoietic tumors (79) .
Viruses, in addition to a well-characterized exploitation of mitosis-promoting genes in the viral life cycle, also use anti-apoptotic genes to protect against host cell death (98 (110) . FAST may therefore be a substrate of the pro-apoptotic phosphatases described above. Moreover, the 
CONCLUSIONS
The Fas/APO-1 receptor plays a central role in mammalian tolerance to self-antigen and cellmediated cytotoxicity. Over the past year, several studies have elucidated aspects of Fas/APO-1 signaling which make it possible to draw a speculative model for the Fas/APO-I pathway (Fig. 2) By analogy with the signaling processes governing proliferation and differentiation, the signal for programmed cell death seem to converge on an evolutionarily conserved set of reactions. Thus, the details of programmed cell death regulation in other organisms are relevant to Fas/ APO-1 signaling. Many unresolved issues remain: (i) which, if any, of the known Fasinteracting proteins are used to transduce Fas/ APO-1 signals, and how does signal modification occur, (ii) how do these signals lead to the activation of the protease, and (iii) how does the protease induce cell death? Answers to these questions will permit not only a better understanding of this basic biological process, but also the prospect of developing therapeutic agents for those conditions in which programmed cell death plays a role. 165 
